|
 New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA by Dave Royse2 min read 15 hours ago  JNJ MNK TEVA It appears more and more likely a case against opioid manufacturers and distributors will proceed to trial in New York state, keeping Bank of America bearish on the companies despite recent performance. The recent denial of a motion to delay the case — which the state brought against the companies —and other factors make it look likely it will go to trial as scheduled March 20, BofA Securities analyst Jason Gerberry said in a Monday note. That's leading Gerberry to keep Underperform ratings on industry stocks in his coverage, including opioid manufacturers Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and Mallinckrodt PLC (NYSE: MNK), even though they've generally outperformed the market. |
|
| aus der Diskussion: | Teva |
| Autor (Datum des Eintrages): | Einkaeufer (11.02.20 11:27:56) |
| Beitrag: | 4,028 von 5,545 (ID:62643505) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |